235 related articles for article (PubMed ID: 16424218)
1. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1.
Tsatsanis C; Androulidaki A; Alissafi T; Charalampopoulos I; Dermitzaki E; Roger T; Gravanis A; Margioris AN
J Immunol; 2006 Feb; 176(3):1869-77. PubMed ID: 16424218
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
3. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.
Arranz A; Androulidaki A; Zacharioudaki V; Martinez C; Margioris AN; Gomariz RP; Tsatsanis C
Mol Immunol; 2008 May; 45(10):2970-80. PubMed ID: 18336909
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.
Bondeva T; Roger T; Wolf G
Am J Nephrol; 2007; 27(3):308-14. PubMed ID: 17495427
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
10. Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.
Dermitzaki E; Liapakis G; Androulidaki A; Venihaki M; Melissas J; Tsatsanis C; Margioris AN
PLoS One; 2014; 9(5):e97060. PubMed ID: 24835211
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
12. The effects of CRF and urocortins on the sociability of mice.
Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G
Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
14. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
15. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
16. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
17. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
[TBL] [Abstract][Full Text] [Related]
19. The effects of CRF and urocortins on the preference for social novelty of mice.
Bagosi Z; Czébely-Lénárt A; Karasz G; Csabafi K; Jászberényi M; Telegdy G
Behav Brain Res; 2017 May; 324():146-154. PubMed ID: 28189757
[TBL] [Abstract][Full Text] [Related]
20. Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.
Parham KL; Zervou S; Karteris E; Catalano RD; Old RW; Hillhouse EW
Endocrinology; 2004 Aug; 145(8):3971-83. PubMed ID: 15142984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
